Skip to main content

Table 1 Demographic, clinical and sputum characteristics for those patients whose sputum was viable for analysis (n = 17,693)

From: Underestimation of airway luminal eosinophilia by quantitative sputum cytometry

  Female, n (%)* Age, years* Daily dose ICS (mcg)* On ICS, n (%)* Daily dose OCS (mg)* On OCS, n (%)*
  7296 (56.2) 58.0 (30.6) 637.9 (633.1) 13,298 (75.2) 3.4 (16.5) 5713 (32.3)
Viability Differential cell count, 106/g (%)#
Total cells Neutrophil Eosinophil Macrophage Lymphocyte Bronchial epithelial
75.0 (0–100) 6.0 (0.1–398.1) 63.3 (0.3–100) 0.8 (0–97) 28.0 (0–99) 0.6 (0–26.7) 0.0 (0–52.0)
  1. ICS Inhaled corticosteroids; Fluticasone equivalent; mcg microgram; OCS oral corticosteroids, mg milligram, g gram. *expressed as mean (standard deviation); #expressed as median (minimum–maximum)